Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival

BACKGROUND: Bortezomib offers a novel approach to the treatment of multiple myeloma producing rapid control. The aim of this study was to investigate the outcomes of bortezomib and dexamethasone-treated patients with multiple myeloma. METHODS: We conducted a retrospective study of 44 consecutively-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiba, Takayoshi, Ito, Takuo, Nakashima, Toshihisa, Okikawa, Yoshiko, Kido, Miki, Kimura, Akiko, Kameda, Keita, Miyamae, Fumiaki, Tanaka, Suzuko, Atsumi, Misao, Sumitani, Yoko, Shitakubo, Yoshimi, Niimi, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078016/
https://www.ncbi.nlm.nih.gov/pubmed/24952705
http://dx.doi.org/10.1186/1471-2407-14-462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078016/
https://www.ncbi.nlm.nih.gov/pubmed/24952705
http://dx.doi.org/10.1186/1471-2407-14-462

Ejemplares similares